If January and February are a sign of things to come in 2021, traders and investors are going to make a lot of money this year. 4 hot penny stocks are Argo Blockchain (OTCMKTS: ARBKF), Integrated Ventures (OTCMKTS: INTV), Novan (NASDAQ: NOVN), and Senseonics Holdings (NYSEAMERICAN: SENS).
HOW TO TRADE HOT PENNY STOCKS
First up, it’s important to understand that trading hot penny stocks is not the same as trading blue chips. As we have stressed repeatedly to our subscribers, the key to trading hot penny stocks is finding momentum BEFORE it happens and then be patient.
Now, when we say that we find momentum BEFORE it happens, we are investors looking to position our subscribers BEFORE the move happens.
We got our subscribers in early on TSNP, which you can read our first article here, and ALPP, which you can read about here. This is where the big money is made and why so many of our subscribers are sitting on gains of over 9633% in ALPP and over 19,900% in TSNP.
It’s also best to own a portfolio of hot penny stocks. For some that can be as many as 10 to 20 or more hot penny stocks.
We always alert our subscribers first before we publish for our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here. We alert our subscribers with our best ideas before our regular readers.
Now we know many prefer to day trade, but we are not day traders here at Insider Financial. It doesn’t suit our personality and we don’t like the intraday moves markets make. We have found we made more money being patient and ignoring the day to day noise of the markets.
If you want to day trade, Insider Financial is not the place for you. When it comes to day trading, and if that’s what you are after, we recommend the folks at True Trading Group, which you can check out their live streams here.
OTC HOT PENNY STOCKS VS NASDAQ/NYSE PENNY STOCKS
The fact is that there is always a bull market somewhere. That’s why it’s important for hot penny stock investors to trade both OTC and NASDAQ/NYSE hot penny stocks. There are always opportunities if you give yourself the flexibility to trade all markets.
Last year, for the first half of 2020, it was much more profitable to trade NASDAQ hot penny stocks than OTC. That is where we and our subscribers were positioned. We captured the runs in SRNE, NIO, INO, IBIO, WKHS, and many others. Then once the summer came, many of the COVID runners had failed to find momentum. We then pivoted to OTC and caught the runs in TSNP, ENZC, MMEDF, and many others.
So far this year, it’s best to play both OTC and NASDAQ/NYSE hot penny stocks. There is no shortage of multi-baggers in both markets at the moment. As we have said repeatedly, there’s no better time to be a hot penny stock trader and traders need to be aggressive. It’s like being at the casino. When you have a hot hand and the house keeps losing (hedge funds and institutions), take advantage of it while you can.
In this article, we take a look at 4 hot penny stocks ARBKF, INTV, NOVN, and SENS to find out what’s behind the move and our outlook for each.
Hot Penny Stock ARBKF
ARBKF is an exciting blockchain play running off the crypto boom. Argo Blockchain is the leading cryptocurrency miner based in the UK.
The company just signed an LOI with DPN LLC of New York, setting out the terms for Argo to acquire 320 acres of land in West Texas, USA, with access of up to 800-megawatts of electrical power where Argo intends to build a new 200mw mining facility in the next 12 months.
When completed, this facility will provide Argo with electricity at some of the lowest rates in the world with the majority from renewable sources.
Peter Wall, Chief Executive of Argo Blockchain, said: “We are incredibly excited about this proposed acquisition. It gives Argo tremendous control over its mining operations, as well as significant capacity for expansion. In addition, we have been able to secure access to some of the cheapest renewable energy worldwide in a location where innovation in new technologies is encouraged and incentivised.”
As part of this project, Argo will also gain access to a pre-negotiated US$100 million credit facility at competitive rates. This will provide Argo with sufficient debt capital to build out the facility and further expand its mining fleet to upscale the Company’s operations and capacity.
During the month of January, Argo mined 93 Bitcoin or Bitcoin Equivalent (BTC) compared to 96 Bitcoin Equivalent in December.
At the end of January, the company held 501 BTC in Bitcoin and BTC equivalents. In the second half of January, the Company purchased a total of 172.5 BTC as part of its asset management strategy. Argo’s total mining capacity is currently 787 petahash (SHA-256) in addition to 280 Megasols of equihash mining capacity.
Hot Penny Stock INTV
INTV is another exciting blockchain play running off the crypto boom. Integrated Ventures is a technology portfolio holdings company with a focus on blockchain technology and cryptocurrency mining.
The Company is booking its highest revenues to the date, with 3 full months to be reported on Q3 report. INTV is in process of raising additional capital and plans to purchase Avalon 1246 miners from Canaan with hashing rates of 85TH/87TH/90TH.
INTV is also cleaning up its balance sheet. During Q1/2020, the convertible debt obligations were greatly reduced. The Company projects the balance sheet to be 100% convertible debt-free, by 03/15/2021.
INTV is one of the best crypto plays for hot penny stock investors as its current market cap is only around $45 million.
Hot Penny Stock NOVN
NOVN is running as the company completed patient enrollment in the B-SIMPLE4 pivotal Phase 3 clinical study of SB206, a topical antiviral gel, for the treatment of molluscum contagiosum.
Those that have been in NOVN for while know that last year the stock got clobbered after trial data regarding its main drug candidate SB206 – failed to achieve statistically significant results for the primary endpoint of the trial – which was the clearance of molluscum at week 12 of treatment.
We said back in June that despite failing to achieve significant goals, the company touted the drugs “near statistical significance” and positive portions of both trials as evidence that the drug does have a measurable improvement in patients.
Novan is taking what it learned from that failure and trying again. This time, we think the company will be successful.
Molluscum contagiosum is a common, contagious skin infection caused by the molluscipoxvirus, affecting approximately six million people in the U.S. annually, with the greatest incidence in children aged one to 14 years.
B-SIMPLE4 is a multi-center, double-blind, randomized, vehicle-controlled study. The Company exceeded its enrollment target of 850 patients (1:1 randomization) in the study, across 55 clinical sites, due to the number of patients in screening at the time of achieving the trial’s stated goal.
Patients will be treated for 12 weeks with a follow-up visit at Week 24. The primary endpoint for the study is the proportion of patients with complete clearance of all treatable molluscum lesions at Week 12 (Intent-to-Treat or “ITT” population, where the analysis assumes that patients with missing data at Week 12 are assessed as treatment failures).
Topline efficacy results from the B-SIMPLE4 study are anticipated before the end of the second quarter of 2021, subject to the targeted timing and trial execution plan which have been and maybe further impacted by the COVID-19 pandemic.
There are currently no FDA-approved therapies for the treatment of molluscum. The Company believes that SB206 as a topical, at-home, caregiver-applied therapy with a rapid treatment benefit if approved, would satisfy an important patient-care need for the treatment of molluscum.
With a market cap of just $300 million, there’s more room for NOVN to run, especially with topline data coming at the end of Q2.
Hot Penny Stock SENS
SENS has been a huge runner to kick off 2021 by rising almost 400%. SENS started running in December after announcing Q4 net revenue is expected to be ~$3.5M, up from the previous forecast of $2.5M, ahead of the consensus of $2.5M. SENS also reached an agreement with Roche to facilitate the transition of distribution to Ascensia, as Roche sales conclude January 31, 2021.
Senseonics Holdings is a medical technology company focused on the design, development, and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease.
Senseonics’ CGM systems, Eversense® and Eversense® XL include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.
SENS is collaborating with Ascensia when it comes to marketing and distribution. The Eversense device will benefit from Ascensia’s large footprint in Medicare and allow them to do the heavy lifting on Senseonic’s behalf.
Last month, EmblemHealth started providing coverage for the Eversense CGM System. This recent coverage decision added to the growing number of payers who are writing Eversense into their CGM coverage policies, as well as paying for the healthcare provider’s time for the in-office sensor placement.
SENS was also able to raise $100 million last month at $1.925 a share. The company is now fully-capitalized and still a bargain at current levels considering the long runway of growth with a breakthrough product, more models to come, and an experienced distribution partner.
We don’t see SENS as being classified as a penny stock much longer.
These 4 hot penny stocks are on the run right now. There are always opportunities in the markets and it’s our job to find winning stocks. Huge gains can be made in such a short amount of time.
For those that missed out on the recent run in these 4 hot penny stocks, our best advice is to be patient and throw bids in below the market. Buying dips and selling rips as swing trades remains the best strategy in these markets.
Remember, all it takes is one or two to become a winner and you’ve crushed the market indices for the year. Whoever said to avoid hot penny stocks has no clue what they’re doing.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.